PepGen is a pioneering brand that is revolutionizing the treatment of neuromuscular diseases using their Enhanced Delivery Oligonucleotide (EDO) platform. With a focus on targeting the root cause of serious genetic diseases, PepGen is creating a pipeline of disease-modifying therapeutics that have the potential to safely and effectively transform the lives of individuals affected by these diseases. Their cutting-edge genetic therapies are designed to treat degenerative neuromuscular diseases, offering hope for improved outcomes and a brighter future.

PepGen is committed to making a difference and is actively seeking passionate individuals to join their team in creating innovative therapies for people living with neuromuscular diseases. As a brand, they prioritize scientific advancements and are dedicated to nurturing a strong community of professionals who share their vision. To stay updated with the latest developments, PepGen regularly provides press releases on their website, announcing significant milestones and breakthroughs in their research.

With their headquarters in Boston, Massachusetts, PepGen is leading the way in empowering oligonucleotide therapeutics and transforming the landscape of genetic medicine